Bilateral jaw fracture after long term treatment with bisphosphonates. A case report.

  1. Cariati, Paolo 1
  2. Sánchez López, Darío 1
  3. Pérez de Perceval, Miguel 1
  4. Valencia, Alfredo 1
  5. Gracia Medina, Blas 1
  1. 1 Universidad de Granada
    info

    Universidad de Granada

    Granada, España

    ROR https://ror.org/04njjy449

Revista:
Actualidad médica

ISSN: 0365-7965

Any de publicació: 2016

Tom: 101

Número: 798

Pàgines: 115-116

Tipus: Article

DOI: 10.15568/AM.2016.798.CC03 DIALNET GOOGLE SCHOLAR lock_openAccés obert editor

Altres publicacions en: Actualidad médica

Resum

Bisphosphonates represent type of medication used for treating numerous pathologies. In fact, more and more clinicians utilize bisphosphonates for dealing oncological diseases, rheumatic pathologies and severe osteoporosis. Despite its benefits, various undesirable side effects have also been associated with the use of these drugs. For instance, patients who receive bisphosphonates present a greater risk of suffering osteonecrosis of jaw. Indeed, the possibility of experiencing this complication is around 0,812% when bisphosphonates are administered intravenously. In contrast, the risk is about 0,01% with oral administration. However, when a tooth extraction is carried out the risk rises to 0,34%. This report presents the case of a 66 years old woman who suffered a bilateral jaw fracture after prolonged treatment with bisphosphonates. Interestingly, no invasive dental procedures were referred by patient. The main aim of this paper is to focus the attention on the serious complications that this treatment may show in the long term.